Viatris launches heart failure drug Inpefa in UAE Jan 20, 2026 07:00AM
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure Jan 20, 2026 06:59AM
Viatris names Andrew Enrietti as chief administrative and transformation officer Aug 19, 2025 09:01AM
Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer Aug 19, 2025 09:00AM
Viatris phase 3 blepharitis drug study fails to meet primary endpoint Jul 18, 2025 06:59AM
View Older Stories

Jul 18, 2025 06:59AM Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
Jul 18, 2025 06:59AM Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
Jun 26, 2025 06:55AM Viatris Inc (VTRS) Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141
Jun 26, 2025 06:55AM Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia
Jun 2, 2025 01:28PM VTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
Jun 2, 2025 08:00AM Viatris Inc (VTRS) Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142
Jun 2, 2025 08:00AM Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
May 31, 2025 12:14PM VTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
May 30, 2025 12:08PM VTRS FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
May 28, 2025 04:12PM VTRS DEADLINE: ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - VTRS
May 26, 2025 11:59PM VTRS DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - VTRS
May 25, 2025 11:54PM VTRS DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Acti
May 24, 2025 10:38AM VTRS IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action
May 22, 2025 11:55PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 21, 2025 11:51PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 19, 2025 10:12PM ROSEN, A LEADING NATIONAL FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 18, 2025 10:12PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 14, 2025 09:08PM ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 13, 2025 08:49PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 12, 2025 08:44PM ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 11, 2025 08:39PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 9, 2025 09:32PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 8, 2025 06:59AM Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
May 8, 2025 06:46AM Viatris Inc (VTRS) Reports Positive Results from Phase 3 Study of Investigational XULANE LO Low Dose Patch
May 8, 2025 06:45AM Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential
May 8, 2025 06:31AM Viatris Inc (VTRS) Reports Positive Top-Line Results from Two Pivotal Phase 3 Studies of MR-107A-02
May 8, 2025 06:30AM Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
May 7, 2025 07:54PM ROSEN, A LEADING AND RANKED FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 7, 2025 06:59AM Viatris Announces Quarterly Dividend
May 5, 2025 09:34PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 5, 2025 04:30PM Viatris Inc (VTRS) Appoints Frank D'Amelio and Michael Severino to its Board
May 5, 2025 04:30PM Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
May 3, 2025 12:03PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
May 2, 2025 11:56AM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 30, 2025 03:43PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 29, 2025 01:17PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 27, 2025 11:18AM ROSEN, A LONGSTANDING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 26, 2025 11:30AM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 25, 2025 06:59AM Viatris to Present at the BofA Securities 2025 Healthcare Conference
Apr 24, 2025 03:14PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 23, 2025 12:01PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 21, 2025 05:11PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 21, 2025 06:59AM Viatris Inc (VTRS) Files sNDA to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
Apr 21, 2025 06:59AM Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
Apr 20, 2025 11:17AM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 18, 2025 09:55PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 17, 2025 05:54PM ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 15, 2025 02:12PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 14, 2025 02:06PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Apr 14, 2025 06:59AM Viatris Inc (VTRS) Appoints Hemanth J. Varghese as Chief Strategy Officer
View Older Stories